Q-Cells® Capabilities

Initial Q-Cell® studies and pre-clinical testing have revealed many unique and promising capabilities:

When injected into myelin-defective models, Q-Cells differentiate into both types of glia: Oligodendrocytes (stained in green) and Astrocytes (stained in red).

In models of human disease that involve defective myelination, Q-Cells® provide robust production of normal myelin.
In these models, Q-Cells® injected into the central nervous system know what to do. They replicate for a limited time, migrate and differentiate normally into mature glial cells:

Oligodendrocytes that produce the insulating myelin sheath on neurons, and

Astrocytes that produce important growth factors and provide trophic support to oligodendrocytes and neurons.

By producing these two types of mature glial cells, Q-Cells® efficiently produce normal myelin.
Q-Cells® produce growth factors that, in addition to supporting myelination, may also lead to treatments for other diseases such as amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease) and Parkinson's Disease.
Q-Cells® can be used as drug screening tools to identify other potential pharmaceutical products.